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Abstract
Functional morphodynamic behavior of differentiated macrophages is strongly controlled by actin cytoskeleton
rearrangements, a process in which also metabolic cofactors ATP and NAD(H) (i.e. NAD+ and NADH) and NADP(H) (i.e.
NADP+ and NADPH) play an essential role. Whereas the link to intracellular ATP availability has been studied extensively,
much less is known about the relationship between actin cytoskeleton dynamics and intracellular redox state and NAD+-
supply. Here, we focus on the role of nicotinamide phosphoribosyltransferase (NAMPT), found in extracellular form as a
cytokine and growth factor, and in intracellular form as one of the key enzymes for the production of NAD+ in macrophages.
Inhibition of NAD+ salvage synthesis by the NAMPT-specific drug FK866 caused a decrease in cytosolic NAD+ levels in RAW
264.7 and Maf-DKO macrophages and led to significant downregulation of the glycolytic flux without directly affecting cell
viability, proliferation, ATP production capacity or mitochondrial respiratory activity. Concomitant with these differential
metabolic changes, the capacity for phagocytic ingestion of particles and also substrate adhesion of macrophages were
altered. Depletion of cytoplasmic NAD+ induced cell-morphological changes and impaired early adhesion in phagocytosis of
zymosan particles as well as spreading performance. Restoration of NAD+ levels by NAD+, NMN, or NADP+ supplementation
reversed the inhibitory effects of FK866. We conclude that direct coupling to local, actin-based, cytoskeletal dynamics is an
important aspect of NAD+’s cytosolic role in the regulation of morphofunctional characteristics of macrophages.
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Introduction
Important elements of neutrophil and monocyte/macrophage
function in innate immunity like cell adhesion, locomotion,
phagocytosis and regulation of cell shape are determined by their
ability to regulate actin cytoskeleton reorganization [1]. Multiple
regulatory principles, established via differentiation programming,
play a role in this coupling. After extravasation, monocytes
migrate into target tissue areas and differentiate into macrophages.
In response to environmental cues, macrophages become polar-
ized, giving rise to different macrophage subtypes. Although other
nomenclature has been suggested [2], phenotypically polarized
macrophages are broadly classified as classically activated M1 and
alternatively activated M2 macrophages [3,4]. In vitro, differenti-
ation toward an inflammatory M1 subtype can be induced by
lipopolysaccharide (LPS) stimulation, while IL-4 and IL-13
promote the alternative activation of macrophages towards a
suppressive M2 subtype. In keeping with their differential roles in
either the initial immune response or the resolution phase of
inflammation and tissue healing, the typical morphodynamic
activities, including adhesion to the extracellular matrix, or the
capturing, adhesion and internalization of cells, debris, or foreign
particles via phagocytosis, differ between the M1- and M2-
polarized macrophages. Recent work has demonstrated that also
the mode of migration, amoeboid or mesenchymal, in 2D and 3D
environments differs [5]. However, as pointed out by Cougoule
and co-workers it is important to realize that distinction between
macrophage shape and motility behavior is often based on in vitro
studies and that in vivo, macrophages may occur in a continuum of
phenotypes, with less explicit differences between differentiation-
induction effects on morphofunctional properties. Diversity in
macrophage phenotype is thus to a large extent the result of
variable cues from the tissue microenvironment [6].
One of the most variable environmental cues is nutrient
availability which may be dramatically reduced in diseased tissue
due to local disruption of the normal blood flow. Macrophages
have been shown to sense changes in nutrient availability via
sirtuin-1 (SirT1) [7] and modulate the inflammatory response
accordingly. Here, we study with a M1 macrophage model
whether the metabolic state also has control over one archetypal
process in this response, the dynamic remodeling of the actin
cytoskeleton that follows induction with bacterial products (like
LPS) and the stimulation of phagocytosis by foreign particles [8,9].
Multiple actin-associated proteins have a role in the spatiotempo-
ral aspects of this remodeling. For proper regulation of actin
polymerization and the activity of accessory proteins the cell
requires sufficient ATP [10–12], supplied via either glycolysis or
mitochondrial oxidative phosphorylation (OXPHOS) in a locally
demand-controlled manner [13,14]. That tight regulation of fuel
supply is also important for macrophage function is illustrated by
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the observation that glucose influx through GLUT1 is enhanced
when macrophages are exposed to LPS [15], or that glucose
consumption via glycolysis is increased when macrophages are
incubated with zymosan [16]. Unfortunately, not much more is
known about the relative contributions of cytoplasmic and
mitochondrial energy-redox reactions to specific morpho-physio-
logical functioning of these cells, although macrophage activities
are thought to be generally more dependent on glycolytic
metabolism than on oxidative pathways [17–19]. In order to
produce ATP in sufficient quantities and sustain a high flux
through glycolysis, glycolytic cells such as macrophages [20] need
to maintain a delicate NAD+/NADH balance and threshold
concentration of NAD(H) (i.e. oxidized and reduced form) in the
cytoplasm. In order to achieve this, NAD+ can be synthesized
de novo from tryptophan, although most of the cellular NAD+ in
mammalian cells comes from salvage pathways using the NAD+
precursors nicotinamide (NAM), nicotinic acid (NA), or nicotin-
amide riboside (NR) as starting substrates [21]. The first reaction
in the conversion of NAM to NAD+ is catalyzed by nicotinamide
phosphoribosyltransferase (NAMPT) and is the rate limiting step
in the pathway, yielding nicotinamide mononucleotide (NMN) as
intermediate product.
NAMPT, also known as pre-B cell colony-enhancing factor
(PBEF) or visfatin, is one of the more than hundred gene products
that undergo conspicuous upregulation upon functional differen-
tiation of macrophages [22,23]. Apart from having an intracellular
enzymatic function in NAD+ salvage synthesis, NAMPT is also
secreted into the extracellular environment [24–26]. Extracellular
NAMPT (eNAMPT) appears not to exhibit enzymatic activity but
functions as a cytokine by inducing pro-inflammatory responses in
macrophages and neutrophils, a role that is unaffected by
treatment with the specific inhibitor FK866 (also known as
APO866) [27–29]. In contrast, inhibition of intracellular NAMPT
(iNAMPT) by FK866 decreases intracellular NAD+ and LPS-
stimulated TNF levels in THP-1 cells and primary mouse and
human monocytes as well as IL-1b and IL-6 levels in mouse
monocytes [30–32]. These observations suggest that a global link
exists between NAD+ salvage metabolism and the inflammatory
response of M1 macrophages. However, whether there is coupling
to specific aspects of macrophage functioning or a role of NAD+/
NADH compartmentalization over mitochondrial and cytosolic
pools [33,34] therein, has not yet been determined.
We have recently, by genetic and pharmacological modulation
of NAMPT-dependent NAD+ salvage synthesis, provided evidence
for a controlling role of NAD(H) (predominantly cytosolic
NAD(H)) in the motile behavior of malignant glioma cells [33].
Here we extend this work by extrapolation of these findings to the
metabolic control over cellular functions in macrophages. We
report on a specific link between cytoplasmic NAD+ homeostasis
and aspects of adhesion, spreading and phagocytosis in LPS-
stimulated cells from the RAW 264.7 lineage and in continuously
proliferating MafB/c-Maf deficient (Maf-DKO) macrophages
[34]. Pharmacological inhibition of NAMPT was used as a tool
to selectively and differentially modulate intracellular NAD+
concentration.
Materials and Methods
Reagents
FK866 was obtained from Enzo Life Sciences (Antwerpen,
Belgium). All other reagents were obtained from Sigma-Aldrich
(St. Louis, MO, USA), unless stated otherwise.
Cell Culture
RAW 264.7 cells (gift from Dr. Hong-Hee Kim, Department of
Cell and Developmental Biology, School of Dentistry, Seoul
National University, Korea; [35]) were maintained in high-glucose
DMEM (Gibco, Life Technologies, Paisley, UK) supplemented
with 10% heat inactivated FBS (PAA laboratories, Pasching,
Austria), 1 mM sodium pyruvate, and 4 mM GlutaMAX (Gibco,
Life Technologies, Paisley, UK), at 37uC in a humidified
atmosphere with 7.5% CO2. Maf-DKO cells (gift from Dr.
Michael H. Sieweke, Centre d’Immunologie de Marseille-Luminy
(CIML), Universite´ Aix-Marseille, France; [34]) were maintained
in the same way except that medium was supplemented with 20%
conditioned medium from L929-cells containing macrophage
colony stimulating factor (M-CSF).
DNA Constructs and Transfection
pEYFP-N1-DATG-Lifeact was constructed as follows: Lifeact
[36] cDNA, containing human codon sequences flanked by a 59
BglII and 39 EcoRI restriction site, was synthesized by GenScript
Corporation and provided in a pUC57 plasmid. The Lifeact-
fragment did not contain a Kozak sequence, therefore, a forward
primer (59-CT CAG ATC TCC ACC ATG GGC GTG GCC
GAC C-39) was designed to induce a BglII site and a Kozak
sequence in front of the Lifeact start codon and used together with
the M13 universal reverse primer to amplify Lifeact from pUC57
by PCR. PCR products were digested with BglII and EcoRI and
ligated into pEYFP-N1-DATG plasmid DNA (pEYFP-N1 from
Clontech with ATG on position 679 mutated to GCG). For
transfection, cells were seeded in 6 well plates at 300 000 cells/well
and incubated overnight. DNA (12 mg; linearized with AseI) was
diluted in 1 ml serum-free DMEM and incubated for 20 minutes
at 37uC with 24 ml Targefect-RAW transfection reagent (Target-
ing Systems, El Cajon, CA, USA). Transfection complexes (250 ml)
were added to wells containing 2 ml fresh culture medium and
incubated for 4 hours at 37uC after which medium was refreshed.
A stable cell population was established by culturing cells for two
weeks in medium containing 500 mg/ml G418 and cloning by
limited dilution.
NAMPT and NAPRT Expression
NAMPT and NAPRT expression was analyzed by western blot
analysis. Whole cell lysates were prepared using 5x SDS-sample
buffer (10% (w/v) SDS, 25% b-mercapto-ethanol, 50% glycerol,
0.05% w/v bromophenolblue, and 312.5 mM Tris-Cl, pH 6.8)
and stored at 220uC until analysis. Before lysates were loaded
onto 12% SDS-PAGE gels, they were heated at 95uC for
5 minutes. After electrophoretic separation, proteins were blotted
onto PVDF membranes. Membranes were blocked with 5%
skimmed milk in PBS-T (NAMPT) or TBS-T (NAPRT) for 1 hour
and labeled overnight with a-Tubulin (1:5000; DSHB, University
of Iowa) and either a-NAMPT (1:2500; Bethyl Laboratories,
Montgomery, TX, USA) or a-NAPRT (1:1000; Sigma-Aldrich,
St. Louis, MO, USA) antibodies at 4uC. After washing the
membranes three times for 5 minutes with PBS-T or TBS-T, they
were incubated with IRDye secondary antibodies (GaR800 and
GaM680) for one hour at room temperature. This was followed by
4 wash steps of 5 minutes each in PBS-T or TBS-T, a final wash
step in PBS, and signal detection on the Odyssey Infrared Imaging
System (LI-COR Biosciences, Lincoln, NE, USA). Cell lysate from
mouse embryonic fibroblasts (MEFs) was used as positive control
for detection of NAPRT.
NAD+ Controls Macrophage Morphodynamics
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NAD(H)/NADP(H) Measurements
Intracellular NAD(H)/NADP(H) was measured according to
the protocol published by Wosikowski et al. [37]. Cells (2.06106)
were seeded in 25 cm2 tissue culture flasks and incubated in either
control medium or medium with 10 nM FK866 for 3, 6, 15, or 24
hours prior to sample collection. Cells were detached mechanically
by scraping in fresh culture medium and counted. Suspensions of
2.06106 cells were spun down and cell pellets were resuspended in
2 ml 0.9% NaCl (Merck, Darmstadt, Germany), split in two and
kept on ice. Both fractions were spun down and NaCl was
removed. One fraction was used to measure NADH and NADPH
levels, and the other fraction was used to measure NAD+ and
NADP+ levels. For NAD(P)H measurement, cell pellets were
resuspended in 200 ml 0.02 M NaOH (Merck, Darmstadt,
Germany) containing 0.5 mM L-cysteine (Merck, Darmstadt,
Germany) and incubated at 60uC for 10 minutes. The alkaline
lysates were then neutralized with 60 ml 0.5 M Gly-Gly buffer,
pH 7.6, and kept on ice. For NAD(P)+ measurement, cells were
lysed in 200 ml ice cold 0.5 M perchloric acid (PCA; Fluka) and
incubated at 4uC for 15 minutes. The acidic lysates were
neutralized by initially adding 80 ml 2 M KOH/0.2 M KH2PO4,
pH 7.5, and adjusting the pH by further addition of 1–5 ml buffer
until reaching neutral pH. Extracts were centrifuged at
13,000 rpm at 4uC for 3 minutes. Supernatants were snap frozen
in liquid nitrogen and stored at 220uC until analysis. NAD(P)+/
NAD(P)H was measured spectrophotometrically in an enzymatic
cycling assay. The NAD+/NADH content of 10 ml sample was
measured in 140 ml reaction mix containing 1.8 mM 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, 70 mM 1-
methoxy-5-methyl-phenzzinium methyl sulfate, 64 mM nicotin-
amide, 0.32 M ethanol, 64 mM Gl-Gly buffer (pH 7.4), 20 mM
succinate (SAFC supply solutions), and 20 U alcohol dehydroge-
nase. The NADP+/NADPH content of 10 ml sample was
measured in 140 ml reaction mix containing 1.8 mM 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, 70 mM 1-
methoxy-5-methyl-phenzzinium methyl sulfate, 5 mM glucose-6-
phosphate, 50 mM Tris-HCl (pH 8.0; Invitrogen), 20 mM succi-
nate, and 0.45 units glucose-6-phosphate dehydrogenase. After
addition of reaction mixes, plates were incubated at 37uC for 30–
60 minutes and absorbance measured at 510 nm on a BioRad
Benchmark Plus micro plate reader. NAD(H) and NADP(H)
concentrations were calculated from an NAD+ and NADP+
standard curve, respectively. Absorbance values were corrected for
blank absorbance (without NAD+ or NADP+) before concentra-
tions were determined. All samples were corrected for the dilution
factor.
NAD(P)H Autofluorescence Measurements
Cellular autofluorescence was determined as a measure of
mitochondrial NAD(P)H-level. Cells were seeded in glass-bottom
WillCo dishes and incubated with or without 5 nM FK866 for 24
hours. Using the 340 nm filter block, cells were exited for 500 ms
and autofluorescence was recorded of at least 10 different fields
using the Olympus IX-71 wide field fluorescence microscope
(Olympus Mitico) equipped with an EM-CCD camera (Hama-
matsu ImagEM). Per field analyzed, the background fluorescence
as well as the fluorescence of each cell in the field was measured by
determining the average grey value of two regions of interest in the
background of the image and of two regions of interest in the cell
body. Per cell, the autofluorescence was determined by subtracting
the average background fluorescence from the average fluores-
cence inside the cell. Per condition, 80–110 cells were analyzed.
Glucose and Lactate Assays
Glucose consumption measurements were based on the Amplex
Red Glucose/Glucose Oxidase assay kit from Molecular probes
(Life Technologies, Eugene, Oregon, USA). Glucose, glucose
oxidase, and Amplex Red reagent were used from the kit but
horseradish peroxidase was obtained from Sigma-Aldrich (St.
Louis, MO, USA) and 1x reaction buffer was replaced with 0.05
M Tris-HCl, pH 7.5. Apart from these minor changes, the kit
protocol was followed as described by the manufacturer. Lactate
production was measured using the same protocol as for glucose
consumption but replacing glucose oxidase with lactate oxidase
and including a lactate standard series instead of glucose. Cells
were seeded in 12 well tissue culture plates and incubated for 24
hours in either 1 ml control or 1 ml 5 nM FK866 medium. For
glucose measurements, medium containing 5 mM glucose was
used while lactate production was measured for cells grown in
25 mM glucose medium. After 18 hours, medium was refreshed in
some wells for measurement of glucose consumption or lactate
production during the last 6 hours of incubation. Prior to addition
of incubation media, wells were always rinsed with pure DMEM
containing no glucose. Medium was collected at the end of the 24
hour incubation period and supernatants were snap frozen in
liquid nitrogen and stored at 220uC until analysis. Cytosolic
extracts were prepared in lysis 100 buffer (50 mM Tris-HCl
pH 7.5, 100 mM NaCl, 5 mM MgCl2, and 0.5% NP-40; 4uC)
and total protein was determined with the Bradford assay. Glucose
consumption was calculated by subtracting the amount of glucose
in the sample from that in medium without cells. Lactate
production was calculated by subtracting the concentration of
any lactate in the medium without cells from that of the samples.
Glucose and lactate assays were performed in parallel.
ATP Assay
Intracellular ATP was determined using the CellTiter-Glo cell
viability assay kit from Promega. A total of 500,000 cells were
seeded per well of a 6-well plate and treated with 5 nM FK866 for
1, 3, or 24 hours prior to assay. Cells were washed twice with ice
cold PBS and then scraped in 350 ml ice cold 0.6 M perchloric
acid (PCA; Fluka). PCA extracts were centrifuged for 3 minutes at
4000 rpm and 4uC to pellet all cellular protein. Supernatants were
neutralized with 140–155 ml 2 M KOH/0.2 M KH2PO4, pH 7.5
and diluted 1:10 in water. Per well, 100 ml diluted PCA extract
was added to 100 ml CellTiter-Glo reagent and the ATP
concentration was determined using an ATP standard series. For
determination of total cellular protein, pellets were dissolved in
250 ml 1 M NaOH and heated for 30 minutes at 95uC. Protein
concentration was then measured in 1:50 diluted NaOH extracts.
Oxygen Consumption Measurements
Mitochondrial respiration was assessed by measuring oxygen
consumption on an Oroboros Oxygraph-2 k respirometer accord-
ing to a standard protocol provided by the manufacturer. Control
and 24 hour FK866 treated cells were analyzed in parallel in two
separate chambers of the respirometer. After air calibration of
control or FK866 medium in the chambers and stabilization of the
signal, 16106 cells (in 60 ml medium) were injected into the
respective chambers. Basal respiration rate was measured at the
point where the O2-flux signal stabilized. Oligomycin (2.5 mM)
was added to each chamber and the leak respiration rate was
determined after stabilization of the signal. Next, 7 mM carbonyl
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, a mitochon-
drial uncoupler) was added to reach maximal oxygen consumption
in the cells. Finally, 30 nM rotenone was added and after
stabilization of the system, the residual oxygen consumption could
NAD+ Controls Macrophage Morphodynamics
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be determined. The data was analyzed using the DatLab software
provided with the instrument.
Proliferation Assay
For cell proliferation measurement, the protocol developed by
Skehan et al. [38] was used. Cells were seeded in four 96-well
plates (20,000 cells/well) in 100 ml culture medium and incubated
overnight. At T0, the medium of plates T6, T15, and T24 were
replaced with medium containing 0, 1, 5, or 10 nM FK866 and
plate T0 was fixed for sulforhodamine B (SRB) staining of protein
content. After 0, 6, 15, and 24 hours of FK866 treatment, cells
were washed twice with cold PBS and fixed in 10% trichloroacetic
acid (TCA; J.T.Baker, Deventer, Holland) for 1 hour at 4uC. After
fixation, plates were washed five times with water and stored at
220uC until all plates were collected. Cellular protein was stained
with 50 ml 0.5% SRB in 1% acetic acid for 20 minutes after which
wells were washed four times with 1% acetic acid. Plates were
dried at 60uC for 3 hours, protein was dissolved in 150 ml 10 mM
Tris-HCl (pH 10.5), and the absorbance of each well was
measured at 510 nm on a BioRad Benchmark Plus micro plate
reader. Values were corrected for background SRB staining by
subtracting the average absorbance value of wells that contained
medium only, from that of wells with cells.
In order to monitor proliferation up to 72 hours, cells were
seeded at a lower density (7,500/well) to avoid any confluency in
the cell monolayer and incubated in medium with 10 nM FK866
for 24, 48, and 72 hours. Plates were fixed and stained as described
above.
Apoptosis Assay
Apoptosis of cells was measured using a biosensor (pSIVA)
developed by Kim et al. [39]. Briefly, cells (20,000/well) were
seeded in a BD Falcon 96-well imaging plate and incubated
overnight. On the day of assay, cells were washed once with
control or FK866 containing medium before adding 100 ml of
fresh control or FK866 medium containing 8 ng/ml pSIVA or
non-labeled control (generous gift from Dr. Ralf Langen,
University of Southern California). The plate was immediately
imaged for 24 hours, continuously, on a BD Pathway high-content
spinning disc confocal microscope, using a 20x objective and 262
montage capture. Three wells were imaged per condition and the
amount of apoptosis was determined by analyzing the increase in
GFP-signal. For each well the threshold of the whole GFP-image
series was adjusted and the total pixel area/frame was determined
using Fiji imaging software and plotted against time.
Spreading Assay
RAW 264.7 cells expressing Lifeact-EYFP were pre-incubated
in control or 5 nM FK866 medium for 0, 3, 15, or 24 hours before
they were harvested by treatment with 1 mM EDTA/PBS
(10 min at 37uC). After washing, the cells were suspended in
medium with 1% BSA. A recovery period of 20 minutes at 37uC
was allowed before cells were seeded in a fibronectin coated
(50 mg/ml for 2 h at 37uC) BD Falcon 96-well imaging plate at
4000 cells/well. Cell spreading was monitored for three hours by
recording the increase in EYFP-pixel area per cell (20 cells/well)
on a BD Pathway high-content spinning disc confocal microscope,
using a 20x objective and 363 montage capture. In order to
combine the data from three independent experiments (performed
in duplicate), the time axes had to be synchronized. To achieve
this, a Boltzmann simulation curve was produced for each data set
between time points 0 and 200 in steps of 2 minutes using
OriginLab data analysis and graphing software (OriginPro 6.1).
Data sets were then combined and analysed for statistical
significance by applying a repeated measures analysis using
PASW statistics 18 SPSS software. Three time frames (consisting
of 30 data points each) of each FK866 curve were compared with
the corresponding three time frames of the control curve.
Scanning Electron Microscopy
Cells were seeded on 12 mm glass coverslips in 24-well plates
and treated with 10 nM FK866 for 3, 6, 15, or 24 hours. In
addition, cells were activated with 100 ng/ml LPS or left non-
activated. Cells were washed once with PBS and fixed with 2%
glutarealdehyde in 0.1 M sodium cacodylate buffer for 1 hour.
After washing cells twice with cacodylate buffer, coverslips were
stored in the same buffer at 4uC until further fixation with 1%
OsO4 (osmium tetroxide) for 30 minutes. Coverslips were then
washed once with water and dehydrated in a graded series of
alcohol washes. Finally, coverslips were critical point dried and
mounted for scanning electron microscopy (JEOL SEM6340F
Field Emission Scanning Electron microscope).
Cellular Actin Staining
Cells on coverslips were incubated in control or FK866 medium
for 24 hours and stimulated with 100 ng/ml LPS overnight or left
unstimulated. Cells were washed twice with PBS and fixed in 2%
paraformaldehyde in 0.2 M sodium phosphate buffer for
30 minutes. Coverslips were washed twice with PBS and twice
with PBS containing 20 mM glycine (MP Biomedicals, Illkirch
Cedex, France; PBS-G) before permeabilization with 0.1%
saponine/PBS-G for 20 minutes. This was followed by actin
staining with Alexa 568-labeled phalloidin (1:600 in 0.1%
saponine/PBS-G) for 1 hour. Cells were successively washed four
times for 2–4 minutes with 0.1% saponine/PBS-G and once with
PBS alone. Coverslips were removed from wells, rinsed once in
water, air dried, and embedded in MoWiol on microscope slides.
Z-scans consisting of 2560.5 mm sections with the pinhole
adjusted to 1 airy unit were recorded on a Zeiss LSM510 META
confocal laser scanning microscope and merged to one single
image using Fiji imaging software.
Phagocytosis Assay
Phagocytic activity was determined as zymosan ingestion
capacity essentially as described by Kuiper et al. [13]. Zymosan
particles were dissolved in PBS at 10 mg/ml and left to rehydrate
for at least one hour. Next, zymosan was sonicated three times for
5 seconds, spun down, resuspended in carbonate buffer (pH 9.6),
sonicated, and incubated with 1 mg/ml fluorescein isothiocyanate
(FITC) for 1 hour at room temperature, in the dark. After FITC
labeling, zymosan was washed three times with carbonate buffer
and incubated in 1 M Tris-HCl, pH 8.0, for 30 minutes. Zymosan
was then washed twice with PBS and finally resuspended in PBS.
After one more sonication step, FITC-labeled zymosan was
divided in aliquots, frozen in liquid nitrogen, and stored at 220uC.
Phagocytosis assays were performed in 12-well plates in which
100,000 cells were seeded per well the day before. Cells were
incubated in control or FK866 containing medium for 3, 15, or 24
hours prior to assay and activated overnight with 100 ng/ml LPS.
FITC-labeled zymosan particles were complement opsonized by
incubation in FBS for 1 hour at 37uC, washed twice with PBS, and
finally resuspended in serum-free control or FK866 medium. Cells
were washed once with serum-free medium and incubated with
1 ml zymosan suspension for 30 minutes at 37uC. The particle-to-
cell ratio was approximately 10:1. Particle engulfment was
terminated by washing cells twice with PBS and removing
extracellular zymosan by treatment with 500 ml 100 U/ml lyticase
for 10 minutes at room temperature. Successively, cells were
NAD+ Controls Macrophage Morphodynamics
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detached with 0.05% trypsin/0.5 mM EDTA (Gibco, Life
Technologies, Paisley, UK), resuspended in 1 ml medium with
serum, pelleted, and finally resuspended in 200 ml 1% parafor-
maldehyde in PBS. Samples were analyzed by FACS and
phagocytosis efficiency was determined by measuring the fluores-
cence intensity of the FITC positive population as well as the
percentage of cells in that population. The phagocytic index of
each sample was calculated as the product of the mean FITC
intensity of the positive population times the % of FITC positive
cells.
To determine the effect of nucleotide supplementation on the
phagocytosis efficiency of control and FK866-treated cells, RAW
264.7 cells were incubated for 24 hours with 100 mM NAD+,
100 mM NMN or 50 mM NADP+ alone or in combination with
5 nM FK866 and phagocytosis efficiency was determined as
described above.
Adhesion and Internalization Assay
Internalization efficiency was determined essentially as de-
scribed by Sahlin et al. [40]. Cells and zymosan particles were
prepared as for the phagocytosis assay. After 30 minute incubation
with serum opsonized zymosan at 37uC, plates were transferred to
ice and wells were washed twice with ice cold PBS. Cells were then
scraped in 1 ml cold medium, divided in two fractions, transferred
to microcentrifuge tubes, and spun down. One fraction of each
sample was resuspended in 0.05% trypan blue in 13 mM
potassium dihydrogen citrate/saline, pH 4.4, to quench the
fluorescence of all extracellular particles, and the other fraction
in the same buffer but without trypan blue. Samples were analyzed
by FACS.
Statistical Analysis
Data was analyzed either with the Student’s t-test or one-sample
t-test for normalized values. All values are expressed as mean +/2
SEM. Values were considered to be significantly different when p
values were ,0.05.
Results
FK866 Inhibits Cellular NAD+ Synthesis
NAMPT mRNA levels in leukocytes are significantly higher
than average levels in various mammalian tissues as determined by
quantitative real time PCR [24]. However, within the lineage
differences exist between leukocyte subtypes in that monocytes and
granulocytes express higher NAMPT mRNA and protein levels
than lymphocytes. To test if possible variations in mode or
capacity of NAD+ synthesis could also exist among different
macrophage lines, we first determined the relative expression levels
of NAMPT and NAPRT, essential enzymes for NAD+ synthesis
from nicotinamide or nicotinic acid, respectively, in RAW 264.7
macrophages and in MafB/c-Maf deficient (Maf-DKO) macro-
phages [34]. Despite differences in cell origin [34,41,42] and
proliferative doubling between these macrophage subtypes (Figure
S1A), only NAMPT appeared to be expressed at comparable and
detectable level (Figure 1A) in both, suggesting that their capacity
for NAD+ synthesis is similar and primarily determined by the
NAMPT reaction step only. Therefore, we considered modulation
of NAD+ levels by inhibition of NAMPT activity with FK866 a
suitable strategy for our further studies into metabolic-morphody-
namic relationships in macrophages.
Since NAD+ can be converted into other pyridine nucleotides,
we compared not only cellular NAD+ levels but also determined
NADH, NADP+, and NADPH levels in the presence and absence
of FK866. Strikingly, although most mammalian cells contain at
least 5–10 fold more total NAD(H) than NADP(H) [33,43–45],
RAW264.7 macrophages and Maf-DKO macrophages appeared
relatively rich in NADP(H). In RAW 264.7 cells NAD(H) and
NADP(H) levels were about equal (Figure 1B, C, E, F) and in Maf-
DKO cells NADP(H) levels were at least one third of that of
NAD(H) (Figure 1H, I, K, L). Prolonged FK866 treatment
affected NAD(H) and NADP(H) differentially, in a time dependent
manner. Within 3 hours, total NAD+ levels in RAW 254.7 cells
were already reduced by approximately 60% (p,0.05; Figure 1B)
while NADH, NADP+ and NADPH levels remained within the
range of the control (Figure 1C, E, F). After 6 hours of FK866
treatment the levels of NAD+, NADH, and NADPH were
significantly decreased. While NAD+ and NADH fell back to
levels that were barely detectable, the cellular NADPH concen-
tration remained at 30–40% and did not decline further with
prolonged treatment. FK866-mediated NAD(H)-depletion oc-
curred slower in Maf-DKO cells. After 3 hours NAD+ levels were
not significantly affected and although there was a marked
reduction, NAD+ was still not fully depleted after 6 hours
(Figure 1H). A slower proliferation rate of Maf-DKO cells (Figure
S1A), and/or effects of other metabolic differences, may explain
the delayed effect of FK866 inhibition in these cells. Nevertheless,
upon near complete depletion of cellular NAD(H), after 6 hours
for RAW 264.7 and 15 hours for Maf-DKO cells, also NADP(H)
levels were profoundly affected. A significant number of cellular
reactions depend on the NAD+/NADH or NADP+/NADPH
redox potential, rather than on the absolute concentration of the
oxidized and reduced forms of these pyridine nucleotides. We
noticed that the NADPH/NADP+ ratio fluctuated somewhat
(within a two-fold ratio change; Figure 1G, M) during the
monitoring period, both with and without the FK866 inhibitor,
while this seemed less apparent for the NAD+/NADH ratio
(Figure 1D, J). However, at some time points (15 h and 24 h) in
incubations with inhibitor the NAD+ and NADH levels became
simply too low to accurately calculate a ratio. Whether the
fluctuations observed are an experimental artifact or a feature that
is associated with oscillations in cellular redox state, as has been
described for yeast cells [46], remains to be determined.
FK866 Inhibition of NAMPT Reduces Glycolytic Flux but
not Intracellular ATP
Since the NAD(P)(H) profiles of the two macrophage cell lines
were highly similar and FK866 affected the NAD(P)(H) levels to
the same extent, we chose to continue our study with main focus
on the RAW 264.7 cell line and made comparisons with the Maf-
DKO cell line where appropriate. In order to determine the
metabolic effect of NAD+-depletion we assessed glycolytic activity
and ATP production. Other studies already demonstrated that
macrophages depend strongly on glycolysis for cellular ATP
production [20,47]. Instead of complete oxidation via the
mitochondrial route through the TCA cycle and oxidative
phosphorylation (OXPHOS), 80% of the glucose molecules that
are imported, are ultimately converted into lactate [19]. For the
RAW 264.7 lineage we confirmed this picture and found that
,75% of all glucose used is converted into lactate, yielding
approximately 1.5 moles of lactate per mole glucose (ratio of
control bars, Figure 2A, B). In glycolysis, NAD+ is converted into
NADH by glyceraldehyde-3-phosphate-dehydrogenase (GAPDH),
producing 1,3-biphosphoglycerate from glyceraldehyde-3-phos-
phate. In concert therewith, the end reaction of glycolysis
(pyruvate-to-lactic acid conversion by lactate dehydrogenase;
LDH), helps to restore the cytoplasmic NAD+/NADH balance.
Therefore, in view of the crucial role of NAD+ availability in
maintenance of glycolytic flux, and on the basis of our data shown
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Figure 1. FK866 treatment causes a time dependent decrease in cellular NAD+/NADH and NADP+/NADPH content. A, Western blot
analysis of NAMPT and NAPRT expression in RAW 264.7 and Maf-DKO macrophages. Lysate from mouse embryonic fibroblasts (MEF) was used as
positive control for NAPRT expression. Note that relative high amounts of lysate were used (intense tubulin control signal) for detection of NAPRT.
B,C,E,F, Pyridine nucleotide levels in RAW 264.7 cells incubated for the indicated time periods with or without 10 nM FK866. H,I,K,L, Pyridine
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in Figure 1B, we expected a strong effect of FK866 on glycolytic
activity. Metabolic comparison between RAW 264.7 cells cultured
in presence and absence of FK866 confirmed this prediction,
showing a reduction of 65% and 50% in the amount of glucose
consumed and lactate produced, respectively (Figure 2A, B).
Simultaneously, the efficacy of lactate formation increased to 1.8
moles of lactate produced per mole of glucose consumed.
In spite of the significant changes in glycolytic activity, we did
not observe a significant effect on cellular ATP production
capacity. Intracellular [ATP] measured at time points 3, 15, and
24 h after FK866 addition remained in range of the control
(around 0.3 mM/mg protein after 3 hours and 0.2 mM/mg protein
after 15 and 24 hours; Figure 2C), whereas NAD+ levels were
already significantly reduced at these time points (Figure 1B). The
30–40% drop in ATP level that occurred in RAW 264.7 cells after
15 and 24 hours was observed repeatedly and can be best
explained as a direct result of medium depletion.
Inhibition of NAMPT-mediated NAD+ Synthesis does not
Affect Mitochondrial Respiration
A large fraction of the cell’s content of reduced pyridine
nucleotides is compartmentalized in the mitochondria. Cellular
NAD(P)H autofluorescence is therefore considered a reliable
measure for assessing the mitochondrial NAD(P)H status [48]. We
utilized this parameter to determine whether FK866 mediated
inhibition of NAMPT affected mitochondrial NAD(P)(H) pools of
RAW 264.7 cells. Although the autofluorescence intensity of 24
hour FK866-treated cells was reduced by 38% (Figure 2D), it did
not mirror the dramatic (60–90%) reduction observed in total
cellular NAD(P)H after 24 hours (Figure 1C, F). One possible
explanation for this apparent discrepancy may be that FK866
hardly affects mitochondrial NAD(P)(H) levels (see also Pittelli et
al. [49]). However, controversy exists around the source of
mitochondrial NAD(P)+ [50,51], as the level of this pool appears
still to be linked - directly or indirectly - to the level of cytosolic
NAD(P)+. Therefore, by reducing cytosolic NAD+, NAMPT
nucleotide levels in Maf-DKO cells incubated for the indicated time periods with or without 5 nM FK866. D,G,J,M, NAD+/NADH and NADPH/NADP+
ratios were calculated from the data in A&B, E&F, H&I, and K&L. Data in B-M represent means of three experiments performed in triplicate. ND, not
detected. (N.S., not significant, *p,0.05, **p,0.01, ***p,0.001, unpaired t-test).
doi:10.1371/journal.pone.0097378.g001
Figure 2. The effect of FK866 on RAW 264.7 metabolism. A, B, Glucose consumption and lactate production in the presence and absence of
FK866. Cells were incubated in control or FK866 medium for a total of 24 hours. Glucose and lactate was measured in medium supernatants collected
over the last 6 hours (18–24 h) of incubation. C, Intracellular ATP levels of RAW 264.7 macrophages treated with 5 nM FK866 for 3, 15, or 24 hours. D,
Mitochondrial NAD(P)H-level. Cellular autofluorescence was measured after 24 hour incubation in control medium or medium with 5 nM FK866. E,
After 24 hour pre-incubation with or without FK866, oxygen consumption was measured in suspensions of 16106 cells in either FK866 or control
medium. Control and FK866 treated cells were analyzed in parallel on the same day. The basal oxygen consumption was measured where after
oligomycin, FCCP, and rotenone was added successively in order to determine the leak respiration, maximal respiration (Max), and residual oxygen
consumption (Res). Data in a-c represent means6 SEM of three experiments performed in triplicate, in d means6 SEM of three experiments, and in e
means 6 SEM of five experiments. (*p,0.05, **p,0.01; unpaired t-test).
doi:10.1371/journal.pone.0097378.g002
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inhibition may ultimately affect the mitochondrial pool, but with
differential kinetics.
Another explanation for the roughly one-third shift in
autofluorescence signal would be that adaptation in mitochondrial
OXPHOS occurs, to compensate for the loss in glycolytic ATP-
production. Thereby a situation would be created wherein an
increased fraction of total mitochondrial NAD(H) would appear in
the (invisible) oxidized form (NAD+). In order to obtain a better
view on the consequences for mitochondrial respiration capacity,
we therefore measured basal oxygen consumption in RAW 264.7
cells pre-treated with 5 nM FK866 for 24 hours and also
determined the leak respiration, maximal respiration, and residual
oxygen consumption in the presence and absence of FK866. The
leak respiration gives an indication of the amount of oxygen that is
consumed without producing ATP. The maximal respiration rate
is a measure for the respiration capacity, while the residual oxygen
consumption after addition of rotenone is a measure for oxygen
consumption by systems other than the electron transport chain,
for example NADPH oxidases. Figure 2E shows the respiratory
values obtained after sequential addition of mitochondrial
inhibitors oligomycin, carbonyl cyanide-p-trifluoromethoxyphe-
nylhydrazone (FCCP), and rotenone, after measurement of the
basal respiration rate. Importantly, we found that FK866 did not
affect any of these parameters and therefore left mitochondrial
metabolism virtually untouched. We believe, therefore, that the
decrease in autofluorescence must represent a reduction in total
cellular NAD(P)H, caused by the global FK866-mediated deple-
tion of cytosolic NAD+.
Inhibition of NAD+ Salvage Synthesis does not Affect Cell
Proliferation or Viability
Next, we investigated the effects of blockade in NAD+ salvage
synthesis on cell viability and proliferation capacity. Figure 3A
shows the increase in total protein mass as a consequence of
growth in RAW 264.7 cell populations, cultivated in absence or
presence of different concentrations of FK866. Within the entire
24 hour period of incubation, FK866 at concentrations up to
10 nM had no - or only a very minor - effect on the rate of
proliferation of RAW 264.7 macrophages. Due their slower
growth rate, proliferation of Maf-DKO cells was monitored for 72
hours and also found not to be affected at these concentrations up
to 48 hours (Figure 3B). Furthermore, use of a polarity-sensitive
annexin-based apoptosis biosensor (pSIVA) with switchable
fluorescence states [39] also did not reveal an increase in the
frequency of RAW 264.7 apoptosis within the 24 hours of FK866
treatment (Figure 3C). In contrast, upon cultivation in glucose-free
medium, used as a control-condition for apoptosis induction,
pSIVA signal strength increased strongly, indicating that RAW
264.7 cells underwent massive apoptosis within 10 hours.
Together, these observations indicate that cell viability and cell
growth are not compromised within the test period and under the
conditions used for inhibition of NAD+ salvage synthesis with
FK866.
LPS-stimulated Spreading and Formation of Actin-rich
Membrane Protrusions are Inhibited in FK866 Treated
Macrophages
The immune activity of macrophages requires the dynamic
remodeling of their cortical actin cytoskeleton, active transport of
membrane components, and a diverse set of receptor-ligand
binding reactions at the cell surface. Together, these are processes
with a large cellular energy demand [10,11,13]. Remodeling of the
cytoskeleton and engagement in adhesion to particles, or binding
to other cells or the ECM are also under control of other aspects of
metabolism, including calcium and redox homeostasis [52–56]. In
order to disclose possible involvement of NAD+ in the morpho-
functional behavior of macrophages we first analyzed whether
NAMPT inhibition affected cell surface morphology. Scanning
electron microscopy (SEM) images of resting RAW 264.7 cells
after different FK866 incubation periods revealed no differences
compared to control cells (not shown). Next, we analyzed the
adhesive ability of cells with normal or impaired NAD+ salvage
capacity after LPS-stimulation. Interestingly, the ability to undergo
spreading and the formation of LPS-induced cellular protrusions
appeared affected by NAMPT inhibition. Cells treated with
FK866 failed to spread upon LPS stimulation already after 15
hours (Figure 4A, B) but the effect was most prominent after 24
hours (Figure 4C, D). In order to quantify the effect of FK866 on
cell spreading, we followed the adhesion and spreading of RAW
264.7 cells expressing Lifeact-EYFP in real time. The cells were
stimulated with LPS overnight and pre-incubated with 5 nM
FK866 for 0, 3, 15 and 24 hours after which they were seeded in
96 well plates and allowed to adhere. FK866 clearly inhibited the
spreading ability of the cells in a time dependent manner
(Figure 4E). Three hour pre-incubation with FK866 only had a
minor affect, while spreading was significantly impaired after 15
and 24 hours of NAMPT inhibition. A notable observation was
that 24 hour FK866-treated cells already covered a smaller cellular
pixel area at T0. This may indicate that NAMPT inhibition
affected the pliability of the cells, causing them to maintain a
rounded shape after reaching the well bottom instead of
undergoing ventral flattening. Alternatively, it may indicate that
the formation of cellular adhesion structures has been disturbed.
Using TIRF microscopy we attempted to detect differences in the
formation of actin-based adhesion structures between control and
FK866-treated cells but, unfortunately, our results were inconclu-
sive.
To know otherwise whether the organization of the actin
cytoskeleton of the cells was affected by FK866, cells were again
stimulated overnight with LPS and treated with FK866 for 3, 6,
15, and 24 hours. After this treatment they were fixed and stained
with Alexa568-labelled phalloidin. No difference was observed in
the actin cytoskeleton after 3 and 6 hours of FK866 treatment (not
shown). However, after 15 hours and especially after 24 hours, the
formation of actin-rich membrane structures was disrupted in
FK866 treated cells. Control cells developed multiple cellular
protrusions upon LPS stimulation with a dense and straight
appearance, while this was less well visible or even absent in the
FK866 treated cells (Figure 5A–D). Phalloidin staining of Maf-
DKO cells revealed that the cells themselves as well as their actin-
rich surface structures have a strikingly different morphology
compared to RAW 264.7 cells (Figure S2A, E). Nevertheless, upon
LPS-stimulation, Maf-DKO control cells also developed sharp
membrane protrusions which were, of note, also inhibited in the
presence of FK866 (Figure S2A–H). Blocking of NAD+ salvage
synthesis therefore clearly affects LPS-induced macrophage
morphology, spreading ability, and the formation of actin-rich
membrane protrusions.
Phagocytosis of Serum Opsonized Zymosan is Hampered
when NAD+ Salvage Synthesis is Inhibited
Finally, we assessed NAD+’s role in phagocytosis, the most
typical immune function of macrophages which requires special
morphodynamic activity. The mechanism of phagocytosis shares
many similarities with that of adhesive spreading of cells [57].
Intracellular uptake of FITC-labeled, complement (serum) opson-
ized zymosan (COZ particles) by RAW 264.7 macrophages was
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impaired after 15 and 24 hour FK866 treatment (Figure 6A–C).
Both the percentage of cells that engaged in phagocytosis
(Figure 6A) and the mean fluorescence intensity of active cells
(Figure 6B) were significantly reduced at these two time points. Of
note, at 3 hours of incubation with FK866 we observed no effect,
although the NAD+ level was already significantly lowered
(Figure 1B). In Maf-DKO cells, phagocytosis of COZ was assessed
after 24 hour FK866 incubation and also found to be significantly
inhibited (Figure S3), indicating that both these cell lines rely on
NAMPT-mediated NAD+ synthesis for efficient phagocytosis. In
addition, supplying cells with extracellular NAD+, NMN, or
NADP+ stimulated phagocytosis of COZ and prevented this
inhibitory effect of FK866 (Figure 7). Although it is not exactly
clear how NAD+ and NADP+ are taken up by the cell, this result
further supports our idea that NAD+ is a principal compound in
the control of phagocytosis efficiency and confirms that FK866
exerts its effect on morphofunctional activity via a reduction in
concentration of this pyridine nucleotide.
As the number of actively phagocytosing cells and the number
of COZ particles engulfed per cell (Figure 6A and B, respectively)
do not provide information about the internalization efficiency, i.e.
the fraction of bound COZ particles that is actually engulfed, we
decided to perform also an internalization efficiency assay. Since
the inhibitory effects of 15 and 24 hour NAMPT inhibition were
comparable, we treated cells with FK866 for the entire period of
24 hours. After incubation with COZ, the extracellular particles
were not removed by lyticase, but samples were split and the
fraction of internalized particles determined from the signal ratio
between trypan blue quenched (internal) and total unquenched
fluorescence (see Materials and Methods for details). Figure 6D
shows that the ability to internalize particles was not compromised
in the presence of FK866. The association with the phagocytic
target is a crucial early step in phagocytosis and is mediated by
multiple actin-rich membrane structures (filopodia, pseudopodia,
and membrane ruffles) that are displayed on the cell surface [58–
60]. Macrophages use these protrusive structures to probe the
environment and capture targets for phagocytosis. When com-
Figure 3. Inhibition of NAD+ salvage synthesis with FK866 does not affect proliferation or viability of macrophages. A, B, RAW 264.7
and Maf-KDO proliferation in the presence of different concentrations of FK866, monitored by measuring the increase in protein mass at different
intervals over a 24 or 72 hour period. Data represent means of three independent experiments performed in triplicate. C, RAW 264.7 cell viability in
the presence of 10 nM FK866. The appearance of the fluorescent apoptosis-specific pSIVA signal was recorded over time and the total pSIVA pixel
area was determined per frame using Fiji Imaging software and plotted against time. Lines represent averages from one experiment performed in
triplicate. (N.S., not significant; unpaired t-test).
doi:10.1371/journal.pone.0097378.g003
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bined, the findings listed in Figures 4 and 5, together with the
observation that fewer cells engaged in phagocytosis (Figure 6A)
and their internalization ability was not affected (Figure 6D),
suggest that macrophages treated with FK866 may have lost the
ability to capture COZ efficiently, perhaps by loss of the ability to
form proper membrane protrusions and adherence structures.
Once contact between cell and particle is established, [NAD+]
variation apparently has no effect on successful internalization.
Discussion
Macrophage function involves efficient migration into tissues,
adhesion to the extracellular matrix, probing or sampling of their
extracellular environment via filopodia, and – most importantly -
phagocytosis of the pathogens and foreign particles they encoun-
ter. These processes rely on proper regulation of polymerization
and depolymerization, branching and debranching of the actin
cytoskeleton and on adequate cellular ATP supply, but the precise
metabolic requirements and mechanisms involved are not yet fully
understood. The NAD+ biosynthetic enzyme NAMPT has been
implicated in linking NAD+ metabolism and the inflammatory
cytokine response of monocytes and macrophages and to play a
regulatory role in cancer cell motility [30–33]. Here we have
investigated the importance of NAMPT dependent NAD+
synthesis for the actin driven processes of adhesion and spreading
and phagocytosis in macrophages. As a novel finding we report
that these morphofunctional activities depended heavily on NAD+
availability, even under metabolic conditions whereby cell growth
and viability and intracellular ATP levels appeared not (yet!)
affected. How these metabolic and morphodynamic activities are
mechanistically controlled remains to be further investigated, but
possibilities are discussed further below and graphically summa-
rized in Figure 8.
Although the biosynthetic pathways involved in the synthesis of
NAD(H) and NADP(H) are generally quite well conserved in
mammalian cells, their synthetic capacity and also the intracellular
levels of NAD(H) and NADP(H) may differ dramatically between
cell types [21,61]. NAD+ can be produced via de novo synthesis
from tryptophan or via three salvage pathways. It also serves as
precursor for the other three pyridine nucleotides, NADH,
NADP+, and NADPH. Its reduced form, NADH, is produced in
reactions catalyzed by dehydrogenases (mainly by LDH and in the
TCA cycle) while NADP+ is synthesized through the phosphor-
ylation of NAD+ by NAD kinase (NADK). NADP+ is subsequently
and very quickly reduced, so that cellular NADP(H) occurs mostly
as NADPH [62]. In contrast, cellular NAD(H) occurs mainly in
the oxidized form, i.e. NAD+. Our measurements shown in
Figure 1 confirm that this general picture also holds for RAW
264.7 and Maf-DKO macrophages. However, one striking
observation was that RAW 264.7 cells contain remarkably high
levels of NADP(H) and appear to maintain these levels during
Figure 4. LPS-stimulated spreading is inhibited during NAMPT
inhibition in RAW 264.7 macrophages. A–D, RAW 264.7 cells were
treated with 10 nM FK866 for 15 or 24 hours and simultaneously
stimulated overnight with LPS. A representative image of each
condition is shown, (Bar = 10 mm). E, To quantify spreading efficiency,
RAW 264.7 macrophages expressing lifeact-EYFP were pre-treated with
5 nM FK866 for the indicated time periods, detached, resuspended,
seeded in 96 well plates and allowed to adhere. Adherence and
spreading of EYFP-positive cells were recorded over time. The average
pixel area per cell was determined at every 10 minute interval. Lines
represent means 6 SEM (grey bars) of three experiments performed in
duplicate.
doi:10.1371/journal.pone.0097378.g004
Figure 5. Actin reorganization is altered during NAMPT
inhibition in RAW 264.7 macrophages. Actin organization was
assessed in wild type cells seeded on glass coverslips, treated with
FK866 for 15 or 24 hours, and simultaneously stimulated overnight with
100 ng/ml LPS. After fixation in 2% PFA, cellular actin was stained with
phalloidin-Alexa568 and cells were imaged on a Zeiss LSM510 META
confocal laser scanning microscope. (Bar = 10 mm).
doi:10.1371/journal.pone.0097378.g005
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FK866 treatment. FK866 inhibition caused a marked reduction in
NAD+ level already after 3 hours of treatment, while NADP(H)
levels were not significantly affected. At later time points, NAD+
and NADH were totally depleted while 40% of the cellular
NADPH still remained. That cellular NAD(H) is more sensitive to
NAMPT inhibition by FK866 was also observed for the Maf-
DKO cell line and for U251 glioma cells and activated T cells in
previous studies [33,63]. Although the mitochondrial NAD(P)(H)-
pool was not left completely untouched, it was clearly less sensitive
to NAMPT inhibition. More importantly, FK866-mediated
NAMPT inhibition did not noticeably affect mitochondrial
respiration. Multiple divergent explanations are possible for these
combined observations. Firstly, mitochondria may not be solely
dependent on NAMPT activity to build up a pool of NAD+. Some
studies show that these organelles do not even contain NAMPT
themselves, although this is an issue of some controversy [49,64].
Figure 6. Phagocytosis efficiency is reduced when NAD+ salvage synthesis is inhibited. Cells were pretreated with 10 nM FK866 for the
indicated times and activated with LPS before they were incubated with FITC-labeled complement opsonized zymosan (COZ) particles for 30 min and
analyzed by FACS. For each sample the percentage of FITC positive cells (A) and mean fluorescence of FITC positive cells (B) were measured. The
phagocytic index (C) was calculated as the product of these two parameters. The internalization efficiency (D) was determined by quenching the
extracellular FITC-COZ of one sample fraction with 0.05% trypan blue in potassium dihydrogen citrate/saline, pH 4.4. Unquenched fractions were
used to determine the total fluorescence per cell (internalized and external particles), while quenched fractions were used to measure only the
internal fluorescence per cell. Data represent means 6 SEM of three assays performed in triplicate. Values were normalized to controls in b and c.
(*p,0.05; paired t-test).
doi:10.1371/journal.pone.0097378.g006
Figure 7. NAD+, NMN, and NADP+ supplementation stimulate phagocytosis and give reversal of FK866 effects. Cells were incubated
for 24 hours with 100 mM NAD+, 100 mM NMN or 50 mM NADP+ in the presence or absence of 5 nM FK866 and activated overnight with LPS before
they were incubated with FITC-labeled complement opsonized zymosan (COZ) particles for 30 min and analyzed by FACS. Values were normalized to
the 0 nM FK866 control. Data represent normalized means 6 SEM of four (0 nM FK866) or three (5 nM FK866) experiments performed in duplicate.
(N.S., not significant, *p,0.05, **p,0.01; paired t-test).
doi:10.1371/journal.pone.0097378.g007
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According to Nikiforov et al. [50], NMNAT3 is the only enzyme
of NAD+ synthesis in mitochondria of human cells. This enzyme
uses NMN, formed by cleavage of cytosolic NAD+, as substrate for
intramitochondrial synthesis of NAD+. However, a more recent
study by Felici et al. [51] contradicts these assertions showing that
cytosolic NAD+ maintains the mitochondrial NAD+ pool and that
neither NMNAT3v1 nor its splice variant FKSG76 is detectable in
human cells. Moreover, upon of transfection of NMNAT3v1,
FKSG76 was the isoform found to be localized to the mitochon-
dria but to be involved in NAD+ splicing rather than synthesis.
What remains, is that the mitochondrial NAD(P)(H) pool in our
macrophage model cells reacts differently, but appears not to be
completely separated from the cytosolic pool. Therefore, the
reduction in mitochondrial autofluorescence signal (Figure 2D)
can be best explained as an effect of a drop in cytosolic NAD+.
The global NAD+ depletion after 24 hours resulted in a reduced
glycolytic rate but the cells nevertheless managed to maintain
cellular ATP production. How this is accomplished is currently not
completely clear to us. Recently Tan et al. [65], showed that
FK866 treatment of cancer cells led to an attenuation of glycolysis
at the GAPDH reaction resulting in a carbon overflow into the
pentose phosphate pathway, a reduced carbon flow into the TCA
cycle, and eventually a reduction in cellular ATP. They also
showed that the inhibitory effect on the TCA cycle was less when
glutamine was not limiting in the culture medium. Since our cells
were cultured in the presence of glutamine and glycolysis was
clearly inhibited, glutamine consumption may have been upregu-
lated in the presence of FK866. Upon glutaminolysis, glutamine is
converted into pyruvate and, finally, lactate via the formation of
TCA-cycle intermediates a-ketogluterate, succinate, fumarate, and
malate, yielding NADH and FADH2 for ATP production via
OXPHOS. This could also explain the minor increase in lactate
formation from 1.5 to 1.8 moles of lactate per mole of glucose
consumed (ratio of bars, Figure 2A, B). We did not observe any
increase in basal mitochondrial OXPHOS activity (Figure 2E),
however, indicating that ATP production was not significantly
upregulated via this route. Thus, any increase in glutaminolysis
probably only matched the reduced carbon flow from glycolysis
into the TCA cycle but did not contribute to ATP homeostasis.
Can we thus rule out limited availability of ATP, due to lack of
NAD+, as the cause of morphofunctional change in FK866 treated
macrophages? Earlier we showed that microcompartmentation of
ATP-supply plays a role in the control of cell migratory activity of
cells [66]. It remains therefore possible that FK866-mediated
NAD+ reduction is associated with a local change in ATP supply
capacity, which may be not sufficient to meet the highly variable
and transient demand for cytoskeletal remodeling and phagocy-
tosis. Under these conditions global cellular ATP concentrations
may not be overtly affected. Interestingly, after 3 hours of
NAMPT inhibition still no inhibitory effect was observed on either
Figure 8. NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages: Synthesis of literature
evidence. NAD+ is required to sustain high glycolytic activity in macrophages. Metabolism of glucose yields cellular ATP which is loaded onto G-
actin monomers by profilin before incorporation into an actin filament, or used to activate the Arp2/3 complex. ATP also binds to Rho GTPase Rho A,
which in turn also stimulates actin polymerization (pink arrows). LPS stimulation induces the expression of the NAD+ synthesizing enzyme NAMPT
(turquoise arrows). NAMPT-mediated NAD+ synthesis may regulate actin dynamics by activating Cdc42 (green arrows) or by influencing cellular
metabolism and, thereby, intracellular pH and cofilin activity (purple arrows). Alternatively, NAMPT may control redox regulation of the actin
cytoskeleton via mical or NADPH oxidase by regulating NADPH levels (orange arrows). GLUT, glucose transporter; NOX, NADPH oxidase; PPP, pentose
phosphate pathway; ROS, reactive oxygen species; SSH-1L, slingshot-1L; TLR4, toll-like receptor 4.
doi:10.1371/journal.pone.0097378.g008
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phagocytosis, spreading, or LPS induced morphology change,
while global NAD+ was already significantly reduced. In addition,
the accumulated glucose consumption and lactate production over
the entire 24 hour incubation period was not significantly different
for control and FK866 treated cells (results not shown). The
decrease in glycolytic flux only became substantial towards the end
of the 24 hour treatment (Figure 2A, B). Thus, if metabolic
coupling of NAD+ concentration to local or global ATP supply is
not the primary mechanism that accounts for FK866 effects on
macrophage morphodynamics, what other mechanisms could be
involved?
Apart from limiting the ATP supply, NAD+-depletion may have
other metabolic consequences that could (directly or indirectly)
interfere with actin dependent morphodynamics. For example, the
production of lactate in the last step of glycolysis, together with
release of protons from the conversion of NADH to NAD+,
influences global intracellular pH (pHi). Locally, the lactate
molecules, when transported out of the cell by the monocarbox-
ylate transporter (MCT1) together with the H+ [67,68], form a pH
gradient across the membrane, which is thought to induce
cytoskeletal rearrangement via actin-binding proteins gelsolin,
cofilin, and talin [69]. By inhibiting the glycolytic flux to lactate,
NAD+-depletion may thus exert direct effects on global and local
pH homeostasis. In line with this, we have recently shown that
both the pHi and the pericellular pH (pHe) of FK866 treated and
NAMPT knockdown U251 cells were elevated compared to
control cells and that the addition of lactic acid to culture media
restored the inhibitory effect of FK866 on U251-shNAMPT cell
migration [33]. Whether [NAD+] changes also cause shifts in
lactate dehydrogenase (LDH) activity in macrophages, and
thereby affect the remodeling of the acto-myosin cytoskeleton in
the micro-environment of phagocytic cup formation remains a
topic for further study.
Upon stimulation with LPS, macrophages undergo dynamic
morphological changes and reorganization of their actin cytoskel-
eton [8,9]. LPS forms a complex with LPS binding protein (LBP)
present in serum, binds to CD14, and finally to the TLR4/MD-2
complex on the macrophage cell membrane [70,71]. LPS
signaling via TLR4 induces Src family kinase mediated phos-
phorylation of Pyk2 and paxillin [8,9,72] as well as phosphory-
lation of the PI3K/AKT pathway [73]. These are molecules
acting upstream of the small GTPases Rho, Rac and Cdc42 which
regulate stress fiber, lamellipodia and membrane ruffle, and
filopodia formation, respectively [74–76]. As a consequence, LPS
stimulation induces cell spreading and the formation of protrusive
membrane structures. In addition, LPS is responsible for the
activation of the complement receptor (CR3) that is involved in the
recognition of serum opsonized particles via Rap1 and RhoA
[77,78]. Together, this enhances the phagocytic capacity of
macrophages. We observed here that NAD+-depletion upon
NAMPT inhibition markedly reduced the phagocytic capacity of
RAW 264.7 and Maf-DKO cells, even though they were still able
to internalize particles once these were bound. Recently, NAMPT
was shown to regulate directionally persistent migration of
vascular smooth muscle cells (SMCs), mediated by Cdc42
activation [79]. Although Cdc42 has been implicated in IgG-
mediated and not CR3-mediated phagocytosis [80], it is also
involved in filopodia formation, the assembly of multimolecular
focal complexes [76], and in integrin-mediated adhesion and
spreading [81] by regulating actin network reorganization via
LIMK2-mediated phosphorylation/inactivation of cofilin [82].
This, in combination with the knowledge that phagocytosis is an
area-restricted form of cell adhesion and spreading [57], suggests
that our findings can also be explained by direct NAMPT activity
effects on the Cdc42-mediated probing, particle capturing, and
adhesion activity of macrophages.
Finally, yet another determinant of proper actin cytoskeletal
remodeling is cellular redox state [53,54], in which NAD+/NADH
and NADP+/NADPH play an important role. In macrophages,
cellular NADPH may influence redox regulation of actin
remodeling in several ways. Professional phagocytes express
NADPH oxidases (NOX) which use NADPH to transfer an
electron to molecular oxygen during the respiratory burst. This
gives rise to superoxide which can further be converted into
hydrogen peroxide (H2O2) and other reactive oxygen species
(ROS), both intra- and extracellularly. Extracellularly and in the
phagosomal lumen, these ROS serve a microbicidal function,
thereby offering protection against pathogens. Intracellularly, the
ROS is involved in redox signaling, mediating the production of
cytokines via NFkb-dependent mechanisms [83] but also regulat-
ing the activity of cofilin [84] which increases the recycling of actin
monomers at the pointed end of actin filaments. At the same time,
NADPH is also responsible for the regeneration of antioxidant
molecules such as glutathione (GSH) and thioredoxin (Trx),
thereby offering protection against oxidative stress, which may
affect the redox state of actin itself [85]. NADPH may also regulate
the balance between ROS-mediated activation/deactivation of
signaling molecules (GTPases) that control the actin cytoskeleton
[54]. Furthermore, NADPH is required for the disassembly of
actin filaments by MICAL redox enzymes [86] which have been
shown to regulate actin dynamics in many cell types [87–90],
including macrophages [91]. Our findings suggest that NADP(H)
may even be a principal pyridine nucleotide in coupling NAD+-
metabolism to actin-based morphodynamics, based on the
following arguments: i) RAW 264.7 cells have a relatively high
level of cellular NADPH, ii) NADP(H) levels were relatively spared
during the initial phases of FK866 inhibition and - in association -
morpho-functional changes became only apparent at later time
points when cellular NADPH reached critical levels, i.e. after 6,
15, or 24 hours of NAMPT inhibition, and finally, iii) supple-
mentation with NADP+ quite effectively rescued phagocytosis in
FK866 treated cells (Figure 7).
Studies during the last decade have identified FK866 as a
promising drug against many different cancers. Currently, this
compound is being tested in phase two clinical trials [92–94].
Tumor cells are more sensitive to inhibition of NAD+ synthesis
than normal cells since they are metabolically highly glycolytic
and, therefore, FK866 is an effective inhibitor of tumor cell
growth. Earlier we have shown in glioma cells [33], and here now
also in macrophages, that morphodynamic behavior (motility,
phagocytosis, spreading) is significantly inhibited at moderately
effective FK866 concentrations, during treatment periods wherein
proliferation and viability were not yet affected. When extrapo-
lating these findings to the in vivo situation, we expect that the
magnitude of effects of FK866 will be dependent on a tumor-cell’s
nutrient state and its capacity for NAD+ synthesis via different
metabolic pathways (i.e. via de novo or salvage pathways, via
NAPRT or NAMPT). Treatment with FK866 may thus have
broad consequences, particularly also for normal glycolytic cells in
tumors such as macrophages. For example, our findings thus leave
open the possibility that FK866 could affect the morphodynamics
of tumor associated macrophages (TAMs), which have a
promoting role in tumor cell migration [95], tumor cell
proliferation and angiogenesis [96]. From a treatment perspective,
this could help to further enhance FK866’s anti-cancer effect. On
the other hand, FK866 treatment could have adverse effects and
lead to an overall repression of macrophage migratory and
phagocytic function, with less clearance of apoptotic cells and
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debris from dying tumors. These effects – even in a more broader
sense – are also a point of concern for use of FK866 as anti-
inflammatory drug for the treatment of autoimmune diseases such
as rheumatoid arthritis, inflammatory bowel disease, or Crohn’s
disease. Further study in patients and animal models in vivo is,
therefore, necessary to fully understand all possible consequences
of FK866 treatment regimes.
In summary, we report here that FK866 mediated inhibition of
NAMPT causes NAD+-depletion and down regulation of glycol-
ysis in macrophage model cells. Inhibition of NAD+ salvage
synthesis did not affect cell viability, proliferative capacity, or ATP
levels but significantly impaired morphofunctional changes
involved in phagocytosis and spreading. Future research should
elucidate how NAD+ production and these processes are exactly
linked.
Supporting Information
Figure S1 RAW 264.7 and Maf-DKO proliferation. A,
Proliferation of RAW 264.7 and Maf-DKO cells in the presence
and absence of L929 cell conditioned medium (M-CSF). B, RAW
264.7 proliferation in the presence of FK866 over a period for 72
hours. Proliferation was monitored by measuring the increase in
protein mass at the indicated time periods. Data represent means
of three independent experiments performed in triplicate. (*p,
0.05, **p,0.01; unpaired t-test).
(TIF)
Figure S2 RAW 264.7 and Maf-DKO morphology and
actin structures are affected during NAD+-depletion.
RAW 264.7 (A–D) and Maf-DKO (E–H) macrophages were
seeded on glass coverslips in RAW264.7 (without M-CSF) and
Maf-DKO (with M-CSF) medium, respectively. Cells were
incubated for 24 h in control 5 nM FK866 medium and
stimulated o/n with 100 ng/ml LPS or left unstimulated. Cells
were fixed in 2% PFA, stained with phalloidin-Alexa568, and
imaged on a Zeiss LSM510 META confocal laser scanning
microscope.
(TIF)
Figure S3 FK866-mediated NAD+-depletion reduces
RAW 264.7 and Maf-DKO phagocytosis efficiency. Cells
were seeded in medium containing 20% conditioned medium
from L929-cell cultures (+M-CSF) and incubated for 24 hours in
the presence or absence of 5 nM FK866. Cells were additionally
stimulated overnight with 100 ng/ml LPS. After 30 minutes
incubation with FITC-labelled complement opsonized zymosan
(COZ) particles, cells were harvested, fixed, and analyzed by
FACS. The percentage of FITC positive cells were measured as
well as the mean fluorescence of this population. The product of
these two parameters were used to calculated the phagocytic
index. Data represent normlaized means 6 SEM of three
experiments performed in duplicate. (*p,0.05; paired t-test).
(TIF)
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